She ties the trend to more women over 40 trying to conceive, and says many are already on peptides at their first visit to her practice.
Recap by typeshit. Post by @eggwhisperer on Instagram.
A general explainer on how GLP-1 receptor agonists affect blood sugar and appetite, with advice on support while taking them.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
Among the items: Walmart plans free GLP-1 diabetes drugs for employees in 2027, and Verdiva Bio dropped a phase II oral GLP-1 study citing market changes.
Longevity Technology reports BodySpec's new offering targets GLP-1 users worried about muscle, with body scans said to take about 12 minutes.
Users describe migraines, eye pain and months of fatigue, as an FDA advisory panel stacked with industry-tied doctors votes to ease limits on six unapproved peptides.
Gelita, Rousselot and Puredia describe demand moving toward precise collagen systems. Rousselot notes GHK-Cu still lacks solid human trial data.
Loading…